menu
    • menu

    Company profile for 89bio

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    89bio is a clinical-stage biopharmaceutical company focused on rapidly advancing our lead product candidate, BIO89-100, through clinical development for the treatment of non-alcoholic steatohepatitis (NASH). BIO89-100 is a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21). It may be a differentiated FGF21 therapy, and we believe it has the potential to become a mainstay of therapy for NASH gi...
    89bio is a clinical-stage biopharmaceutical company focused on rapidly advancing our lead product candidate, BIO89-100, through clinical development for the treatment of non-alcoholic steatohepatitis (NASH). BIO89-100 is a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21). It may be a differentiated FGF21 therapy, and we believe it has the potential to become a mainstay of therapy for NASH given its ability to address the key liver pathologies (steatosis and fibrosis) and underlying metabolic dysregulation in patients with NASH.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    89bioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    142 Sansome Street, 2nd Floor San Francisco CA 94104
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.89bio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Roche Purchases Shares In Tender Offer For 89Bio
    Roche Purchases Shares In Tender Offer For 89Bio

    30 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/30/3177049/0/en/Roche-purchases-shares-in-tender-offer-for-89bio-Inc.html

    GLOBENEWSWIRE
    30 Oct 2025
    Share Share
    How Akero’s MASH Success Drove Roche’s $3.5B Takeout of 89bio
    How Akero’s MASH Success Drove Roche’s $3.5B Takeout of 89bio

    03 Oct 2025

    // BIOSPACE

    https://www.biospace.com/business/how-akeros-mash-success-drove-roches-3-5b-takeout-of-89bio

    BIOSPACE
    03 Oct 2025
    Share Share
    Roche Starts Tender Offer For 89bio At $14.50/share in Cash
    Roche Starts Tender Offer For 89bio At $14.50/share in Cash

    01 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/01/3159980/0/en/Roche-commences-tender-offer-for-all-shares-of-89bio-Inc-for-14-50-per-share-in-cash-plus-a-non-tradeable-contingent-value-right-for-up-to-6-00-per-share-in-cash.html

    GLOBENEWSWIRE
    01 Oct 2025
    Share Share
    Roche Becomes MASH Player via $3.5 B Deal for 89bio, Ph. 3 Drug
    Roche Becomes MASH Player via $3.5 B Deal for 89bio, Ph. 3 Drug

    18 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/18/3152147/0/en/89bio-Inc-Announces-Agreement-to-be-Acquired-by-Roche.html

    GLOBENEWSWIRE
    18 Sep 2025
    Share Share
    89bio Announces Inducement Grants Under Nasdaq LR 5635(c)(4)
    89bio Announces Inducement Grants Under Nasdaq LR 5635(c)(4)

    05 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/05/3145485/0/en/89bio-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    05 Sep 2025
    Share Share
    89bio to Participate in Upcoming Investor Conferences
    89bio to Participate in Upcoming Investor Conferences

    28 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/28/3141118/0/en/89bio-to-Participate-in-Upcoming-Investor-Conferences.html

    GLOBENEWSWIRE
    28 Aug 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search